November 09, 2012
Q-Med AB launched a suit in New York federal court Wednesday seeking to prevent Medicis Pharmaceutical Corp. from transferring marketing rights for Q-Med's skin care products to rival Valeant Pharmaceuticals International Inc., which has announced plans to buy Medicis for $2.6 billion.